Consolidated Statements of Cash Flow - USD ($)	12 Months Ended
	Feb. 28, 2024	Feb. 28, 2023
Cash Flows from Operating Activities:
Net Income (Loss)	$ (2,453,934)	$ (3,527,425)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:
Stock-based compensation expense	627,404	2,121,213
Amortization of debt issuance costs	15,578	72,478
Amortization of debt discount	10,333	51,667
Depreciation	1,156	776
Impairment of goodwill	583,484	0
Loss on debt extinguishment	80,914	0
Amortization of debt premium	4,790	0
Changes in Operating Assets and Liabilities:
Accounts receivable	(1,174)	(1,460)
Inventory	(3,063)	12,127
Prepaid expenses	13,859	0
Other receivable- related party	(5,152)	0
Accounts payable and accrued expenses	207,710	15,422
Accrued interest	105,600	60,243
Deferred compensation	389,151	379,759
Other current liabilities	0	(2,555)
Net Cash Used in Operating Activities	(423,344)	(817,755)
Cash Flows from Investing Activities:
Acquisition of business, net of cash acquired	0	(6,087)
Purchases of property and equipment	0	(2,323)
Net Cash Used in Investing Activities	0	(8,410)
Cash Flows from Financing Activities:
Payment of debt issuance cost	(5,000)	(56,640)
Proceeds from convertible loan, net of original issue discount	65,000	558,000
Proceeds from notes payable related party	403,787	275,500
Repayment of Notes payable- related party	(52,500)	0
Common stock issuance	0	3,750
Expenses contributed to capital	0	49,686
Net Cash Flows from Financing Activities	411,287	830,296
Net (decrease) increase in cash	(12,057)	4,131
Cash at the beginning of the year:	13,773	9,642
Cash at the end of the year:	1,716	13,773
Supplemental Disclosure Of Non-Cash Investing And Financing Activities:
Common stock issued for acquisition	0	550,000
Common stock issued to settle liability	0	17,500
Warrants issued and extended for common stock issuance costs	0	30,702
Discount on notes payable for warrants	0	25,197
Common stock issued for settlement of debt	195,000	0
Preferred stock issuable for assets purchase	56,243	0
Common stock issued for settlement of deferred compensation.	333,103	0
Common stock issuable for settlement of deferred compensation	$ 351,984	$ 0